Into the Eye of the COVID-19 Cytokine Storm
In this episode, we get expert perspectives on the immunopathology and management of the cytokine storm in adult and pediatric patients with COVID-19.
Pediatrics
Higher Rates of Serious Adverse Events in Children With Rheumatic Diseases Receiving Tocilizumab
Researchers assessed the incidence rate and type of serious adverse events in children with inflammatory rheumatic diseases receiving tocilizumab.
Case Report: Anti-Ku Antibodies Identified in Systemic Sclerosis-Polymyositis Overlap Syndrome in an Adolescent
Authors of a report presented the case of systemic sclerosis-polymyositis overlap syndrome in an adolescent with anti-Ku antibodies.
ACR Guidance for the Management of Pediatric Multisystem Inflammatory Syndrome Associated With SARS-CoV-2
The American College of Rheumatology developed guidance for the management of pediatric patients with multisystem inflammatory syndrome associated with COVID-19.
Blood Pressure Dipping May Be a Marker of Cardiovascular Function in Pediatric-Onset SLE
Researchers evaluated blood pressure dipping as a marker of endothelial function and subclinical atherosclerosis in pediatric-onset systemic lupus erythematosus.
Adalimumab Biosimilar Gets FDA Approval for Rheumatic Diseases
The FDA has approved Hulio® (adalimumab-fkjp; Mylan), a biosimilar to Humira® (adalimumab; AbbVie).
New Systemic Inflammatory Syndrome May Be Associated With SARS-CoV-2 in Children
A new systemic inflammatory syndrome, “Kawa-COVID-19,” may be associated with SARS-CoV-2 infection in children.
Factors Linked to Severe COVID-19 in Children Identified
COVID-19 generally causes mild disease in children, with 8% of children requiring intensive care unit admission.
ACR Issues Clinical Guidance for Pediatric Patients With Rheumatic Disease During the COVID-19 Pandemic
The American College of Rheumatology has issued clinical guidance to rheumatology providers for the management of pediatric patients with rheumatic disease during the COVID-19 pandemic.
Long-Term Efficacy of Methotrexate Demonstrated in Pediatric Linear Scleroderma
Researchers evaluated disease course and long-term efficacy of methotrexate treatment in children with linear scleroderma.
-
Loading...
-
Loading...
Next post in Pediatric Rheumatology
